Antineoplastic agents exacerbate periodontal inflammation and aggravate experimental periodontitis.
alveolar bone loss
antineoplastic agents
cisplatin
fluorouracil
periodontal disease
periodontium
Journal
Journal of clinical periodontology
ISSN: 1600-051X
Titre abrégé: J Clin Periodontol
Pays: United States
ID NLM: 0425123
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
24
04
2018
revised:
22
12
2018
accepted:
02
03
2019
pubmed:
12
3
2019
medline:
18
12
2019
entrez:
12
3
2019
Statut:
ppublish
Résumé
This study evaluated the effects of 5-fluorouracil (5-FU) and cisplatin (CIS) in healthy periodontal tissues and in the early stages of experimental periodontitis (EP) in rats. One hundred and eighty male rats were divided into three groups, which were submitted to the following systemic treatments: physiological saline solution (PSS); CIS and 5FU. Each group was subdivided into two subgroups: without (NEP) and with (EP) induction of EP. Animals were euthanized at 3, 5 and 7 days post-treatment. Histological, histometric (percentage of bone in the furcation [PBF]) and immunohistochemical (for tumour necrosis factor-α, interleukin-1β and receptor activator of nuclear factor-κB ligand) analyses were performed. Data were statistically analysed. CIS-NEP and 5FU-NEP showed more inflammation than PSS-NEP at 3, 5 and 7 days. CIS-EP and 5FU-EP showed more inflammation and lower PBF than PSS-EP at all periods of evaluation. 5FU-EP showed lower PBF than CIS-EP at 5 and 7 days. 5-FU and CIS exacerbated periodontal inflammation and aggravated the progression of EP in its early stages.
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
457-469Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.